top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

528.44 +8.83 (+1.70%)

Streaming Delayed Price Updated: 11:07 AM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Madrigal Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

DouYu International Posts Q1 Results, Joins Annexon, Dollar Tree And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 05, 2024

Via Benzinga

Viking Therapeutics Stock Crumbles Despite Potential 'Best-In-Class' Liver Disease Drug ↗

June 04, 2024

Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

Via Investor's Business Daily

The Week Ahead: What's Next ↗

June 02, 2024

The core part of our portfolio is up 24% this year ... and we're about to add another stock. Plus, a riddle.

Via Talk Markets

Is Madrigal Pharmaceuticals Stock a Buy? ↗

May 21, 2024

It's not the most prominent biotech, but it has an important claim to fame.

Via The Motley Fool

MDGL Stock Earnings: Madrigal Pharmaceuticals Misses EPS for Q1 2024 ↗

May 07, 2024

MDGL stock results show that Madrigal Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

2 Under-the-Radar Growth Stocks to Consider ↗

April 10, 2024

Don't ignore these innovative companies.

Via The Motley Fool

1 No-Brainer Growth Stock to Buy Now ↗

April 03, 2024

This liver-disease specialist might be significantly undervalued.

Via The Motley Fool

Here's 1 Huge New Reason to Buy Madrigal Pharmaceuticals Stock ↗

March 26, 2024

This biotech just got clearance to dive into a deep ocean of a market.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 07, 2024

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

May 03, 2024

Via Benzinga

6 Stocks Positioned to Soar as Investors Focus on MASH

April 22, 2024

Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of...

Via TheNewswire.com

7 Stocks Analysts Are Loving Right Now (And You Should Too): April 2024 ↗

April 15, 2024

Analyst-backed stocks have a high correlation with future stock price growth. Here are seven stocks with a high number of recent upgrades.

Via InvestorPlace

Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning Trading

March 15, 2024

Via Investor Brand Network

Better Booming Biotech Stock: Madrigal Pharmaceuticals vs. Viking Therapeutics ↗

April 05, 2024

These businesses should see good times ahead.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy in April 2024 ↗

April 01, 2024

Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.

Via InvestorPlace

2 Top Biotech Buyout Candidates ↗

March 31, 2024

Investors who are adventurous, have a high-risk tolerance, and are home run hitters may opt for biotech stocks. Investors in this group may want to hone in on stocks that have the potential to be...

Via Talk Markets

Better Buy: Viking Therapeutics vs. Madrigal Pharmaceuticals ↗

March 29, 2024

Both stocks are pretty risky, but one of them more so than the other.

Via The Motley Fool

Is This Healthcare Stock a Screaming Buy After Scoring a Huge Drug Approval? ↗

March 29, 2024

Could it be just a matter of time before Madrigal Pharmaceuticals stock takes off?

Via The Motley Fool

7 Stocks That Will Drive the Weight Loss Drugs Market

March 28, 2024

The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis.

Via MarketBeat

This Under-the-Radar Stock Just Hit a Major Milestone: Time to Buy? ↗

March 22, 2024

The mid-cap biotech has succeeded where many others failed.

Via The Motley Fool

Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win? ↗

March 19, 2024

Madrigal has one key advantage over its two huge potential future rivals.

Via The Motley Fool

7 Biotech Stocks Ready to Ride the Sector’s Resurgence ↗

March 18, 2024

With investors seeking new opportunities with certain segments appearing stretched, biotech stocks offer a viable canvas.

Via InvestorPlace

Madrigal Pharmaceuticals Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

March 18, 2024

On Monday, Madrigal Pharmaceuticals stock hit a key technical milestone, seeing its Relative Strength Rating jump to 83 from 69 a day ago.

Via Investor's Business Daily

10 Health Care Stocks Whale Activity In Today's Session ↗

March 18, 2024

Via Benzinga

Madrigal Pharmaceuticals Wins Approval for the First Drug Targeting the Multibillion-Dollar NASH Market. Is the Stock a Screaming Buy? ↗

March 17, 2024

Madrigal's Rezdiffra will have the NASH market all to itself -- at least for a while.

Via The Motley Fool

Why Jabil Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 15, 2024

Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates.

Via Benzinga

FDA Conditionally Approves Madrigal Pharmaceuticals' Resmetirom As First Treatment For Fatty Liver Disease With Scarring ↗

March 15, 2024

FDA's accelerated approval for Madrigal Pharmaceuticals' Rezdiffra for noncirrhotic nonalcoholic steatohepatitis with liver scarring. The first treatment for liver scarring due to fatty liver disease....

Via Benzinga

Why Is Geron (GERN) Stock Up 94% Today? ↗

March 15, 2024

Geron stock is on the rise Friday with heavy trading of GERN shares after the company's blood disorder drug got new backing.

Via InvestorPlace

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday ↗

March 15, 2024

U.S. stocks were lower, with the Dow Jones index falling around 100 points on Friday. Shares of Blend Labs, Inc. (NASDAQ: BLND) rose sharply during Friday’s session after the company reported...

Via Benzinga

Topics Stocks

MDGL Stock Alert: The Historic Reason Madrigal Is Up 19% Today ↗

March 15, 2024

Madrigal Pharmaceuticals stock is up on Friday as MDGL investors celebrate FDA approval of NASH treatment Rezdiffra today.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page